Clinical Trial Information
A 3D Human Tissue-Engineered Lung Model to Study Immune Responses to Respiratory Syncytial Virus- Protocol Number: 14051
- Status: Open
- Age Group: Children
- Treatment Type: Basic Science
- Phase: N/A
Scope Information
- Scope:
- Local
- Disease Site(s):
- Other